M Oguro - Concepedia

Author

M Oguro

Kyoto Prefectural University of Medicine

Also Known As

M OGURO, M Oguro, M. OGURO, M. Oguro, MINAKO OGURO, Oguro, M.

Publications

637

Citations

H-Index

Concepts

All Affiliations

Kyoto Prefectural University of Medicine Niigata University Chiba Cancer Center

About

M Oguro is an author at Kyoto Prefectural University of Medicine specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	466
2	Health Sciences	2	2	68
3	Natural Sciences	1	1	56
4	Anesthesia	1	1	12
5	Biochemistry	1	1	56

M Oguro

Publications

566

Citations

H-Index

Page 1

	Year	Citations
An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. R Ohno, Kosuke Okada, T Masaoka, Journal of Clinical Oncology Hematological MalignancyTumor BiologyLymphoid NeoplasiaOncologyRefractory Cases	1990	229
Carbohydrate structures of human α-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans Yoko Aoyagi, Y. Suzuki, Kazuei Igarashi, British Journal of Cancer GlycoproteomicsHepatologyBiochemistryMedicineLiver Physiology	1993	56
Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Yoko Aoyagi, Atsushi Saitoh, Y. Suzuki, PubMed GastroenterologyPathologyEarly RecognitionSmall Hepatocellular CarcinomaCirrhosis	1993	55
A phase II study of aclacinomycin A in acute leukemia in adults Kazumasa Yamada, Takashi Nakamura, T. Tsuruo, Cancer Treatment Reviews Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderMyeloid Neoplasia	1980	50
Paraventricular Nucleus Lesions Attenuate the Development of Hypertension in DOC A/Salt-Treated Rats Tomoaki Nakata, Kazuya Takeda, HIROYUKI ITHO, American Journal of Hypertension	1989	39
Collateral drug sensitivity induced in CPT-11 (a novel derivative of camptothecin)-resistant cell lines M Oguro, Yasuo Seki, Kosuke Okada, Biomedicine & Pharmacotherapy Drug TargetingNovel DerivativeMedicine-Resistant Cell LinesMechanism Of Action	1990	36
Central Attenuation of Baroreflex by Angiotensin II in Normotensive and Spontaneously Hypertensive Rats Junko Hayashi, K. Takeda, Shingo Kawasaki, American Journal of Hypertension	1988	34
Treatment of multiple myeloma with recombinant human leukocyte A interferon. R Ohno, Kiyoji Kimura, I Amaki, PubMed Hematological MalignancyAutoimmune DiseaseMalignant Blood DisorderHematologyImmunology	1985	15
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study. Toshiyuki Takagi, K Sampi, Umihiko Sawada, PubMed	1993	14
Central Attenuation of Baroreflex Precedes the Development of Hypertension in DOCA - SALT-Treated Rats Kazuya Takeda, Yoshio Nakamura, M Oguro, American Journal of Hypertension	1988	13

Page 1